Infinium Pharmachem Limited is an India-based company. The Company is engaged in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. Its portfolio includes approximately 200+ Iodine Derivatives and seven Active Pharmaceutical Ingredients (APIs). It manufactures and supplies a range of Iodine-based APIs, but on an Order-to-Made basis only. It offers Bulk Actives, intermediates and services for custom synthesis. It also provides contract research and manufacturing services to pharmaceutical and biotech companies for their diverse requirements of Iodine-based APIs and intermediates to reduce their research time and project cost. It manufactures iodine derivatives for various industries, including pharmaceutical, chemical, nutraceutical, cosmetics, sanitation, agrochemical, electronics, nylon production, and other industries for their range of industrial applications.
INFINIUM PHARMACHEM LTD Financial Highlights
- Revenue: INFINIUM PHARMACHEM LTD reported revenue of ₹191.77 crore in FY26 vs ₹157.83 crore in FY25. It showed an increase of 21.50% on a yearly basis.
- Operating Profit: INFINIUM PHARMACHEM LTD reported an operating profit of ₹17.84 crore in FY26 vs ₹11.57 crore in FY25. It showed an increase of 54.19% on a year-on-year basis.
- Net Profit: INFINIUM PHARMACHEM LTD reported a net profit of ₹14.20 crore in FY26 vs ₹7.84 crore in FY25. It showed an increase of 81.12% on a yearly basis.